Arcturus Therapeutics Holdings, Inc. (ARCT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1150522,
    "name": "Arcturus Therapeutics Holdings, Inc.",
    "stock_name": "Arcturus Therapeutics Holdings, Inc.",
    "full_name": "Arcturus Therapeutics Holdings, Inc.",
    "name_url": "stocks-analysis/arcturus-therapeutics-holdings-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.43",
    "chg": -0.09,
    "chgp": "-1.38%",
    "dir": -1,
    "prev_price": "6.52",
    "mcapval": "484.44",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03969T1097",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "1.04 M",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arcturus-therapeutics-holdings-inc-1150522-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $5.85 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-585-amid-financial-struggles-3721526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3721526.png",
        "date": "2025-11-21 15:56:04",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year marked by an 81.5% decline in stock price. The company faces ongoing financial challenges, including negative return on equity, a decrease in net sales, and significant losses in pre-tax profit, amidst a broader market contrast."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $6.02 Amid Major Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-602-amid-major-decline-3718640",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3718640.png",
        "date": "2025-11-20 16:38:12",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 81.06% decline in stock price. The company reported a decrease in net sales and a negative pre-tax profit, alongside ongoing financial difficulties indicated by negative return on equity and EBITDA."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $6.72 Amid Ongoing Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-672-amid-ongoing-struggles-3712540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3712540.png",
        "date": "2025-11-18 17:04:01",
        "description": "Arcturus Therapeutics Holdings, Inc. has hit a new 52-week low, reflecting significant challenges in its financial performance. The company has seen a substantial decline in stock price over the past year, with negative returns on equity and disappointing quarterly results, raising concerns about its future viability."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-726-amid-financial-struggles-3707956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3707956.png",
        "date": "2025-11-17 16:46:02",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company reported a decrease in net sales and consecutive negative quarterly results, alongside a low return on equity, as it faces ongoing financial difficulties."
      },
      {
        "title": "Arcturus Therapeutics Hits New 52-Week Low at $7.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-new-52-week-low-at-776-3702009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3702009.png",
        "date": "2025-11-14 16:00:38",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company faces ongoing financial challenges, including negative return on equity and a decrease in net sales, while its market capitalization stands at USD 484 million."
      },
      {
        "title": "Arcturus Therapeutics Hits 52-Week Low at $7.93 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcturus-therapeutics-hits-52-week-low-at-793-amid-financial-struggles-3686493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcturusTherape_priceRelatedfactors_3686493.png",
        "date": "2025-11-10 17:23:48",
        "description": "Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces ongoing financial challenges, including negative return on equity, a high debt-to-equity ratio, and declining net sales, contributing to its underperformance in the market."
      },
      {
        "title": "Is Arcturus Therapeutics Holdings, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcturus-therapeutics-holdings-inc-technically-bullish-or-bearish-3651550",
        "imagepath": "",
        "date": "2025-10-28 11:45:53",
        "description": "As of 24 October 2025, the technical trend for Arcturus Therapeutics Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, suggesting some short-term strength. However, both the weekly and monthly Bollinger Bands are bearish, which adds caution. The KST shows a bullish signal on the weekly but bearish on the monthly, further contributing to the mixed outlook. Overall, the technical stance is mildly bullish, but the strength is tempered by bearish indicators in the Bollinger Bands and mixed MACD signals. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Arcturus Therapeutics Holdings, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcturus-therapeutics-holdings-inc-technically-bullish-or-bearish-3648003",
        "imagepath": "",
        "date": "2025-10-27 11:56:56",
        "description": "As of 24 October 2025, the technical trend for Arcturus Therapeutics Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some short-term strength. However, the Bollinger Bands are bearish on both weekly and monthly time frames, which adds to the caution. The KST shows a bullish signal weekly but bearish monthly, and there are no clear trends in Dow Theory or OBV. Overall, the stance is mildly bullish but with significant caution due to bearish indicators. Multi-period return data is not available for comparison with the S&P 500...."
      },
      {
        "title": "Is Arcturus Therapeutics Holdings, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcturus-therapeutics-holdings-inc-technically-bullish-or-bearish-3646537",
        "imagepath": "",
        "date": "2025-10-26 11:32:21",
        "description": "As of 24 October 2025, the technical trend for Arcturus Therapeutics Holdings, Inc. has changed from bullish to mildly bullish. The current technical stance is mildly bullish, driven primarily by the daily moving averages indicating a mildly bullish trend. However, the weekly MACD is mildly bearish, and Bollinger Bands are bearish on both weekly and monthly time frames, suggesting caution. The stock has significantly underperformed compared to the S&P 500 across multiple periods, with a 1-year return of -40.95% versus the S&P 500's 16.90%...."
      }
    ],
    "total": 20,
    "sid": "1150522",
    "stock_news_url": "https://www.marketsmojo.com/news/arcturus-therapeutics-holdings-inc-1150522"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Arcturus Therapeutics Hits 52-Week Low at $5.85 Amid Financial Struggles

2025-11-21 15:56:04

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year marked by an 81.5% decline in stock price. The company faces ongoing financial challenges, including negative return on equity, a decrease in net sales, and significant losses in pre-tax profit, amidst a broader market contrast.

Arcturus Therapeutics Hits 52-Week Low at $6.02 Amid Major Decline

2025-11-20 16:38:12

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 81.06% decline in stock price. The company reported a decrease in net sales and a negative pre-tax profit, alongside ongoing financial difficulties indicated by negative return on equity and EBITDA.

Arcturus Therapeutics Hits 52-Week Low at $6.72 Amid Ongoing Struggles

2025-11-18 17:04:01

Arcturus Therapeutics Holdings, Inc. has hit a new 52-week low, reflecting significant challenges in its financial performance. The company has seen a substantial decline in stock price over the past year, with negative returns on equity and disappointing quarterly results, raising concerns about its future viability.

Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles

2025-11-17 16:46:02

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company reported a decrease in net sales and consecutive negative quarterly results, alongside a low return on equity, as it faces ongoing financial difficulties.

Arcturus Therapeutics Hits New 52-Week Low at $7.76

2025-11-14 16:00:38

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company faces ongoing financial challenges, including negative return on equity and a decrease in net sales, while its market capitalization stands at USD 484 million.

Arcturus Therapeutics Hits 52-Week Low at $7.93 Amid Financial Struggles

2025-11-10 17:23:48

Arcturus Therapeutics Holdings, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces ongoing financial challenges, including negative return on equity, a high debt-to-equity ratio, and declining net sales, contributing to its underperformance in the market.

Is Arcturus Therapeutics Holdings, Inc. technically bullish or bearish?

2025-10-28 11:45:53

As of 24 October 2025, the technical trend for Arcturus Therapeutics Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, suggesting some short-term strength. However, both the weekly and monthly Bollinger Bands are bearish, which adds caution. The KST shows a bullish signal on the weekly but bearish on the monthly, further contributing to the mixed outlook. Overall, the technical stance is mildly bullish, but the strength is tempered by bearish indicators in the Bollinger Bands and mixed MACD signals. Multi-period return data is not available for comparison with the S&P 500....

Is Arcturus Therapeutics Holdings, Inc. technically bullish or bearish?

2025-10-27 11:56:56

As of 24 October 2025, the technical trend for Arcturus Therapeutics Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some short-term strength. However, the Bollinger Bands are bearish on both weekly and monthly time frames, which adds to the caution. The KST shows a bullish signal weekly but bearish monthly, and there are no clear trends in Dow Theory or OBV. Overall, the stance is mildly bullish but with significant caution due to bearish indicators. Multi-period return data is not available for comparison with the S&P 500....

Is Arcturus Therapeutics Holdings, Inc. technically bullish or bearish?

2025-10-26 11:32:21

As of 24 October 2025, the technical trend for Arcturus Therapeutics Holdings, Inc. has changed from bullish to mildly bullish. The current technical stance is mildly bullish, driven primarily by the daily moving averages indicating a mildly bullish trend. However, the weekly MACD is mildly bearish, and Bollinger Bands are bearish on both weekly and monthly time frames, suggesting caution. The stock has significantly underperformed compared to the S&P 500 across multiple periods, with a 1-year return of -40.95% versus the S&P 500's 16.90%....

View All News